Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing

被引：2

作者：

Warren, Julia T. ^{[1
,2
]}

Dickerson, Kathryn E. ^{[3
]}

Sharathkumar, Anjali A. ^{[4
]}

Walter, Jolan E. ^{[5
]}

Wilson, David B. ^{[6
]}

Adell, Katrina P. ^{[7
]}

Chen, Kelly ^{[7
]}

Dubuc, Susan ^{[7
]}

MacLeod, Rick ^{[7
]}

Peters, Katie ^{[7
]}

Stewart, Murray ^{[7
]}

Taveras, Arthur G. ^{[7
]}

Walkovich, Kelly ^{[8
]}

机构：

[1] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Hematol & Oncol, Dallas, TX 75390 USA

[4] Univ Iowa Hlth Care, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA USA

[5] Univ S Florida, Johns Hopkins All Childrens Hosp, Morsani Coll Med, Div Allergy & Immunol,Dept Pediat, St Petersburg, FL USA

[6] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA

[7] X4 Pharmaceut Inc, Boston, MA USA

[8] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-173549

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Phagocytic Function in Neutropenic Neonates Treated with G-CSF
Magdy Ahmad
Edmund F LaGamma
Howard Fleit
Mark Golightly
Pediatric Research, 1999, 45 (7) : 260 - 260
[2] Phagocytic function in neutropenic neonates treated with G-CSF
Ahmad, M
LaGamma, EF
Fleit, H
Golightly, M
PEDIATRIC RESEARCH, 1999, 45 (04) : 260A - 260A
[3] Lung abscess secondary to neutropenic myelodysplasia treated with G-CSF
Guilleminault, L.
Espanel, C.
Marcq, M.
Azzouz, M.
Diot, E.
Binet, C.
Diot, P.
REVUE DES MALADIES RESPIRATOIRES, 2009, 26 (01) : 87 - 89
[4] Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy
Tidow, N
Pilz, C
Kasper, B
Welte, K
STEM CELLS, 1997, 15 : 113 - 119
[5] Immunotherapy with G-CSF in patients with chronic mucocutaneous
van de Veerdonk, Frank L.
Koenen, Hans J. P. M.
van der Velden, Walter J. F. M.
van der Meer, Jos W. M.
Netea, Mihai G.
IMMUNOLOGY LETTERS, 2015, 167 (01) : 54 - 56
[6] Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy - Discussion
Fibbe
Welte
Lowenberg
Ihle
STEM CELLS, 1997, 15 : 120 - 120
[7] G-CSF And GM-CSF Therapy in Neonatal Infection: Preliminary Results of A Multicenter Study
G Chirico
F Kanakoudi-Tsakalidou
V Drossou-Agakidou
S Fotopolous
K Pavlou
E Starnacosta
M Xanthou
Pediatric Research, 1999, 45 : 762 - 762
[8] PROSPECTIVE MULTICENTER RANDOMIZED TRIAL COMPARING ANTIFUNGAL EFFECT OF GM-CSF, G-CSF, OR COMBINATION OF GM-CSF AND G-CSF FOR NEUTROPENIC RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTATION
Wan, L.
Wang, C.
Zhou, J.
Lai, Y.
Jiang, M.
Song, Y.
BONE MARROW TRANSPLANTATION, 2014, 49 : S81 - S82
[9] Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.
Karanth, M
Harvey, C
Chakrabarti, S
Holder, K
McConkey, CC
McDonald, D
Lovell, RA
Fegan, CD
Milligan, DW
BLOOD, 2002, 100 (11) : 826A - 826A
[10] Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Reda, Manon
Macaire, Pauline
Bellio, Helene
Uwer, Lionel
Ilie, Silvia
Lorgis, Veronique
Hennequin, Audrey
Ladoire, Sylvain
Rederstorff, Emilie
Fumoleau, Pierre
Isambert, Nicolas
Bonnin, Nathalie
You, Benoit
Freyer, Gilles
Desmoulins, Isabelle
Schmitt, Antonin
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (02) : 197 - 208

← 1 2 3 4 5 →